HGP-1910
- Generic Name
- HGP-1910
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 57
- Registration Number
- NCT04762407
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia
Phase 3
Completed
- Conditions
- Primary Hypercholesterolemia
- Interventions
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 279
- Registration Number
- NCT04652349
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath